Warning!
Your browser does not support HTML5.
Display of the content may be incorrect. Please make sure that your browser supports HTML5 syntax.
Search for Small Molecules by SMILES, name, CAS, MFCD, ID, InChI Key
Search for Biologics by ID, Target name, CAS, Protein name, Gene ID, Clone ID, Source Organism
Home CSSS07096534801

Structure Info


Chemspace ID
CSSS07096534801 (In-Stock Screening Compounds)
CAS
586971-29-1
IUPAC Name
(2S)-2-amino-3-(3,4-dihydroxyphenyl)(1-¹³C)propanoic acid
Mol formula
C9H11NO4
Mol weight
198 Da
Catalog Number(s)
AA02APT1, AG02APVT, BM59137, CS-0542040, HY-N0304S2, Y3295334

Properties

LogP
-1.79
Heavy atoms count
14
Rotatable bond count
3
Number of rings
1
Carbon bond saturation, Fsp3
0.222
Polar surface area (Å)
104
Hydrogen bond acceptors count
5
Hydrogen bond donors count
4

SDS

Choose Language:

If you wish to request SDS before ordering, please contact us at [email protected]

Items Overall 6 items from 2 suppliers

SupplierLead timeShips fromPurityPackPrice, $Qty
MedChemExpress10 daysUnited States
To:
981 mg120
Go to cartEnquire
MedChemExpress10 daysUnited States
To:
985 mg250
Go to cartEnquire
MedChemExpress10 daysUnited States
To:
9810 mg400
Go to cartEnquire
Description: Names: L-DOPA-13C; Product Description: L-DOPA- 13 C is the 13 C labeled L-DOPA L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA has anti-allodynic effects and the potential for Parkinson's disease; Target: Dopamine Receptor;Endogenous Metabolite; CAS: 586971-29-1
MedChemExpress EU10 daysSweden
To:
981 mg126
Go to cartEnquire
MedChemExpress EU10 daysSweden
To:
985 mg263
Go to cartEnquire
MedChemExpress EU10 daysSweden
To:
9810 mg421
Go to cartEnquire
Description: Names: L-DOPA-13C; Product Description: L-DOPA-13C is the 13C labeled L-DOPA L-DOPA (Levodopa) is an orally active metabolic precursor of neurotransmitters dopamine. L-DOPA can cross the blood-brain barrier and is converted into dopamine in the brain. L-DOPA has anti-allodynic effects and the potential for Parkinson's disease; Target: Dopamine Receptor;Endogenous Metabolite; CAS: 586971-29-1
For a custom pack size or bulk
please drop us a line:Enquire